Table 2.
Risk of Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
| Risk of Suspected NAFLDa in total population | ||||||||
|---|---|---|---|---|---|---|---|---|
| All races (n = 944) | Non-hispanic white (n = 256) | Hispanic (n = 344) | ||||||
| Unadjusted modeld | Adjusted modele | Adjusted modelf | Adjusted modelf | |||||
| OR (95% C.I.)c | p-value | OR (95% C.I.) | p-value | OR (95% C.I.) | p-value | OR (95% C.I.) | p-value | |
| Urinary BPAb Category | ||||||||
| 0.28–1.3 ng/mL | Reference | Reference | Reference | Reference | ||||
| 1.4–2.7 ng/mL | 2.66 (0.94–7.48) | 0.064 | 4.23 (1.44–12.41) | 0.010 | 1.69 (0.26–10.92) | 0.571 | 6.12 (1.62–23.15) | 0.009 |
| 2.8–5.4 ng/mL | 1.95 (0.57–6.71) | 0.281 | 2.43 (0.57–10.43) | 0.225 | 1.19 (0.09–15.63) | 0.887 | 2.74 (0.42–17.70) | 0.281 |
| ≥5.5 ng/mL | 2.12 (0.58–7.72) | 0.248 | 3.39 (0.78–14.80) | 0.101 | 1.30 (0.06–27.62) | 0.862 | 4.21 (0.74–24.11) | 0.104 |
| Log Transformed BPA | ||||||||
| 1.07 (0.69–1.67) | 0.757 | 1.20 (0.75–1.91) | 0.444 | 1.22 (0.48–3.12) | 0.674 | 1.02 (0.61–1.72) | 0.937 | |
aNon-Alcoholic Fatty Liver Disease, bBisphenol A, cOdds Ratio (95% Confidence Interval), dAdjusted for urinary creatinine, eAdjusted for urinary creatinine, gender, age, race, family income to poverty ratio, country of birth, total caloric intake in 24 h, cotinine levels, and survey cycle, fAdjusted for urinary creatinine, gender, age, total caloric intake in 24 h, cotinine levels, and survey cycle